Intra-Cellular Therapies, Inc.
Organic compounds
Last updated:
Abstract:
The present invention relates to certain PDE2 inhibitory compounds, in free or salt form, pharmaceutical compositions containing such compounds and methods for the treatment of PDE2 mediated disorders.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2018
Issue date:
28 Jan 2020